‘Super Mario Galaxy Movie’ Powers to $372 Million Globally, ‘Project Hail Mary’ Hits $420 Million

The Super Mario Galaxy Movie opened to $372.5M worldwide (including $182.4M overseas) on a $110M production budget, posting a $22.2M global Imax launch and top overseas markets of Mexico $29M, UK/Ireland $19.7M, Germany $15M and France $12M. Amazon MGM’s Project Hail Mary has grossed $420.7M globally ($203.6M overseas) and pulled in $42.1M from 86 overseas markets in its third weekend (a 23% decline), with both films positioned to dominate the box office through April.

Analysis

The current theatrical environment is signaling that a small number of high-IP, event movies are re-accelerating premium theatrical revenue — disproportionately benefitting firms that capture premium pricing and a larger revenue share (exhibition partners and premium-format licensors). IMAX sits on a structural advantage: fixed supply of premium auditoriums plus a revenue-share model that scales directly with blockbuster box-office concentration, turning a handful of hits into outsized quarterly beats. Universal-style IP owners (studio/brand holders) extract value across merchandising, theme-parks and downstream licensing, but that value realization is lumpy and back-loaded relative to headline box-office receipts.

Second-order beneficiaries include consumer-products licensors, experiential partners (parks/attractions) and ad/brand partners willing to pay up for spectacle-driven reach; second-order losers would be lower-tier theatrical screens and streaming windows if studios accelerate premium-live theatrical windows in future release strategies. Tail risks are concentrated and fast-moving: a single major market regulatory issue (e.g., China access), an abrupt compression of theatrical-to-home windows, or a surprise string of middling follow-ups could flip margins within one fiscal quarter. The appropriate time horizons differ — exhibition upside shows up within weeks/months of release, while studio/brand monetization plays out over 6–24 months and is sensitive to talent backend terms and merchandising saturation.

Key Decisions for Investors

• IMAX (IMAX) — Overweight equity for 6–12 months: initiate a size that equals 2–3% of liquid equities exposure. Rationale: asymmetric upside from continued slate concentration and premium pricing; target a 35–50% upside if next 2–3 event films sustain premium share. Risk management: set a tactical stop-loss of ~15% and trim into outsized single-day moves tied to studio guidance.
• IMAX options — Buy a 4–8 month call spread to gain leveraged exposure while capping premium paid. Trade mechanics: debit spread sized to risk no more than 0.5–1% of portfolio; reward scenario is ~2–3x payoff if box-office momentum continues into the summer slate. This limits tail loss if theatrical attendance cools quickly.
• UVV — Buy-and-write (long shares + sell 12-month covered calls) sized 1–2% of portfolio for 12–24 month thematic exposure to IP monetization and recurring licensing. Rationale: captures cash flow and reduces net basis while retaining upside from merchandising/park reacceleration; expected total return profile is moderate (mid-teens over 12–24 months) assuming stable sequel economics. Downside: use a protective 9–12 month put or collar if you want to limit a >25% drawdown from franchise fatigue.
• Hedge / Pair — If overweight IMAX, hedge studio execution risk by buying a 3–6 month put or put spread on UVV (or on the parent studio if more liquid) sized to offset ~50% of the equity position’s notional. This pair protects against the consensus mistake of extrapolating front-loaded box-office into smooth long-term studio margins and is a cost-effective way to express conviction in exhibition outperformance relative to studio monetization execution.